Cataract development associated with long term glucocorticoid therapy in DMD patients


Glucocorticoid treatment, which has been shown to slow the decline of muscle strength and function in patients with Duchenne muscular dystrophy (DMD), can be associated with significant ocular side effects including cataract formation. However, the existing literature on this subjection is limited. To examine the prevalence and rate of development of cataracts in DMD patients on long term glucocorticoid treatment. This is a retrospective analysis of DMD patients who were evaluated in the Comprehensive Neuromuscular Center at Cincinnati Children’s Hospital Medical Center (CCHMC) between 1/1/2010 through 12/31/2015.


Leave A Reply